CrossMark Policy

DOI: 10.58600/eurjther-2023-crossmark-policy

Articles submitted to the journal are published as advanced online publication/ahead of print (AOP) and author accepted manuscript (AAM) published after peer review.

Crossmark is an initiative to provide a standard way for readers to locate the current version of a piece of content. By applying the Crossmark button, the European Journal of Therapeutics is committing to maintaining the content it publishes, and to alerting readers to changes if and when they occur.

Clicking on the Crossmark button will tell you the current status of a document and may also give you additional publication record information about the document.

For more information on CrossMark, please visit the CrossMark site (